TY - CHAP M1 - Book, Section TI - Intrathecal Drug Delivery Trialing Procedures A1 - Bowman, Richard A1 - Deer, Timothy R. A1 - Pope, Jason E. A2 - Diwan, Sudhir A2 - Staats, Peter S. PY - 2015 T2 - Atlas of Pain Medicine Procedures AB - Intrathecal drug delivery system (IDDS) trials offer the clinician an ability to utilize neuraxial medications in the patient and assess whether or not the patient has a positive response to the medications.By delivering substances in this format, prior to committing the individual patient to surgical implantation of the device, the physician can be cost-effective, selective, and most importantly improve patient efficacy and safety.There are 2 major categories of patients who would be considered for intrathecal pump infusion system trialing in the field of interventional pain management.The first group suffers from neuropathic, nociceptive, or mixed pain syndromes which may be related to cancer pain or noncancer pain syndromes. Trialing often involves a primary opioid, ziconotide, or a combination of medications to treat different types of pain.The second group suffers from poorly controlled spasticity, and involves the injection of baclofen.The mechanics of needle and catheter placement may be similar between these groups; however, the assessment of the individual patient, with respect to outcome, differs significantly.Trialing in the neuroaxis also varies based on the targeted area of drug delivery.Options include single shot injections or catheter placement with intermittent bolusing or continuous infusion, and the anatomical location may be the epidural space or the cerebral spinal fluid. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accessanesthesiology.mhmedical.com/content.aspx?aid=1107200020 ER -